Trial Profile
Efficacy of Liraglutide vs. Sitagliptin vs. Insulin Glargine Per Day on Liver Fat When Combined With Metformin in T2DM Subjects With Non-alcoholic Fatty-liver Disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Oct 2018
Price :
$35
*
At a glance
- Drugs Insulin glargine (Primary) ; Liraglutide (Primary) ; Sitagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms LIGHT-ON
- 19 Oct 2018 Primary endpoint has not been met. (Intrahepatic lipids (IHL); from baseline to week 26 of Insulin glargine), as per the results published in the Hepatology.
- 19 Oct 2018 Primary endpoint has been met. (Intrahepatic lipids (IHL); from baseline to week 26 of Sitagliptin), as per the results published in the Hepatology.
- 19 Oct 2018 Primary endpoint has been met. (Intrahepatic lipids (IHL); from baseline to week 26 of liraglutide), as per the results published in the Hepatology.